The entrepreneurial idea of prof. Ussia receives the "Lazio Region" Special Award
29 October 2020 - Start Cup Lazio supports the creation and accompanies the market of innovative Startups/Spinoffs with a high innovation content coming from the regional system of scientific research and promotes knowledge transfer processes in order to promote the development of the territory and the country through the provision of services at incubators and regional Active Spaces.
It is a real Business Plan Competition promoted by the Universities and research institutions of Lazio in collaboration with prestigious industrial and financial partners, organized and coordinated by the University of Rome "Tor Vergata" in partnership with Lazio region e Lazio Innovates, in which this year the team of teacher. Gian Paolo Ussia, Associate Professor of theResearch Unit of Cardiological Sciences dell 'Università Campus Bio-Medico di Roma.
His business project tetis has been awarded the Special Award "Lazio Region" for access to incubation services at one of the Active Spaces in Lazio on the basis of geographical proximity and the specialization of the proposed solution.
The Tetis project concerns the construction and sale of a multipurpose steerable catheter conceived and designed to improve the results of interventions transcatheter interventional cardiology in patients who cannot perform surgery because they are at high risk. The catheter is extremely versatile: it can be directed in all directions and is made up of several hypotubes which allow the positioning of different devices with different functions, from the needle to perform guided punctures, to grasping forceps or recovery baskets. This would facilitate the recapture and repositioning of prostheses with immediate resolution of complications.
Transcatheter interventional cardiology represents the future of heart disease care as it preserves the integrity of the person, avoids the risks of cardiac surgery, reduces the period of hospitalization and accelerates recovery. In particular, the most demanding and promising challenge is the therapy of heart valve disease.